PPT-PrEP to Prevent HIV and

Promote Sexual Health wwwhivguidelinesorg MAY 2022 NYSDOH AIDS Institute Clinical Guidelines Program Purpose of This Guideline Increase awareness and knowledge of PrEP efficacy among clinicians in NYS. PrEP. New York State Department of Health AIDS Institute. June, . 2014. Objectives. Learn about . PrEP. and how it works. List reasons why gay men and trans people should know about . PrEP. Learn . about PEP and how it is different from . . Edwin J Bernard . Co-. ordinator. , HIV Justice Network. Consultant, GNP+. . “As a woman living with HIV, how I wish that we had known about PrEP then. We knew how to judge our risk and we knew that our risks of getting HIV were high; we would have taken PrEP.” . Katherine Marx, MS, MPH, FNP-BC. June 2014. Disclosure. I, Katherine Marx, have no relevant financial, professional, or personal relationships to disclose.. Objectives. Know current US recommendations for . The . South African experience. Sinead Delany-Moretlwe, . MBBCh. PhD. University of the Witwatersrand. IAS, 26 Jul 2018. TDF/FTC licensed for PrEP in . >40 countries. Included in WHO Essential Medicines List. (PMTCT). What is PMTCT?. The . transmission of HIV from an HIV-positive mother to her child during pregnancy, . labor. , delivery or breastfeeding is called mother-to-child . transmission (MTCT). . WHO 2011. Pre-Exposure Prophylaxis ( PrEP ) for HIV Infection Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health University of California Los Angeles Attending Physician UCLA Center AIDS Research and Education and Ronald Reagan Medical Center PrEP and Men: A man’s got to do, what a man’s got to do. Dr Saiqa Mullick, Wits RHI @ WitsRHI Share your thoughts on this presentation with #IAS2019 Context: It’s time for a conversation about male risk PrEP to Prevent HIV and Promote Sexual Health www.hivguidelines.org Purpose of the Guideline To provide clinicians throughout NYS with the recommendations needed to successfully start and continue patients on PrEP. Patterns of Sex and PrEP in Harlem MSM: A qualitative study (HPTN 067)   1. ICAP, Columbia University Mailman School of Public Health, New York, New York, United States 2. Department of Epidemiology, ICAP, Columbia University Mailman School of Public Health, New York, New York, United States 3. Department of Health Behavior and Health Education, University of Michigan, Ann Arbor, Michigan, United States 4. FHI 360, Durham, North Carolina, United States 5. Fred Hutchinson Cancer Research Center, Seattle, Washington, United States 6. Gladstone Institutes, University of California, San Francisco, California, United States 7. Department of Medicine, Harlem Hospital Center, New York, New York, United States . Final results from the Partners Demonstration Project. Jared M. Baeten, Renee . Heffron. , Lara . Kidoguchi. , Nelly Mugo, . Elly. . Katabira. , Elizabeth Bukusi, Stephen Asiimwe, Jennifer Morton, Kenneth . Kimberly Green. Director, Primary Health Care. PATH. kgreen@path.org. More than . 1.3 million . people took PrEP at least once by June 2021. Source: Jessica Rodrigues, AVAC, IAS2021. PrEP use has accelerated but is still far from meeting . nPEP. Mark Schweizer, DDS MPH. Director Infection Prevention . Progrmas. Nova Southeastern University College of Dental Medicine. Dental Director South Florida Southeast AIDS Education and Training Center . H. Jonathon Rendina (Presenting). Jeffrey T. Parsons, Thomas H. F. Whitfield, Christian . Grov. Presented at the 22. nd. Annual International AIDS Conference. July 24, 2018. Background. Despite high efficacy in preventing HIV transmission, PrEP provides no protection against other sexually transmitted infections (STIs). iPrEx. Trial . Substudy. TDF-FTC versus Placebo as HIV . PrEP. for Transgender Women. iPrEx. . Substudy. : Study Design. Source: Deutsch MB, et al. Lancet HIV. 2015;2:e512-9.. Background. : . Subgroup analysis of the .